The National Academies' will host a workshop to examine the U.S. Food and Drug Administration’s historic and recent use of the Emergency Use Authorizations (EUAs) for diagnostics, therapeutics, and vaccines. The event will provide an overview of the current regulatory framework for EUAs and discuss whether any possible revisions would help to ensure that EUAs
Dr. Colleen Kraft, ASM President Elect, leads an in-depth discussion on how vaccination and therapeutics have been used to address the long-term complications of COVID-19. This free event is brought to you by the 2021 ASM Clinical Virology Symposium (CVS), one of a 4-part CVS Online: SARS-CoV-2 Webinar Series featuring leading experts in the field
The Roundtable on Genomics and Precision Health will host a virtual public workshop that will examine the current state of diversity (e.g., racial, ethnic) of the genetics and genomics workforce, structural issues that have contributed to diversity challenges, and potential steps forward. Workshop discussions may address topics such as the impact of racism on the
On October 5-6, 2021, the Forum on Neuroscience and Nervous System Disorders will host a virtual public workshop that brings together experts and key stakeholders from academia, industry, government, philanthropic foundations, and disease-focused non-profit organizations to discuss new genetic and neuroscience technologies and explore how these discoveries can be used to elucidate disease mechanisms and
The COVID-19 pandemic has created unprecedented challenges for disaster planners and responders, bringing to light both shortfalls and opportunities. The rapid pace of operations and ongoing evolution of the public health emergency have prompted modifications to plans and procedures in emergency response; however, many of the leaders within local and state agencies involved in these
This is the eighth virtual meeting of a consensus study focused on respiratory protection for the public and workers without respiratory protection programs. During the public portion of this meeting, the committee will explore current processes and systems for evaluating infectious agents transmissible by inhalation routes and determining the need for public use of respiratory
Hear from researchers and public health experts on present and future scenarios as they explore the changing landscape of the virus, including the Delta variant's impact on children, and the latest in vaccine availability, hesitancy and boosters. This is the last in a series of three virtual events, hosted by Florida International University in partnership
In 1980 smallpox was declared eradicated after a global vaccination campaign. Today, only two labs in the world retain variola virus, the cause of smallpox, one in the USA and one in Russia – and the World Health Assembly has recommended these virus stocks be destroyed when essential research with variola virus is complete. Professor
Join faculty members from the Schar School’s Biodefense master’s program in a discussion on the future of global health security considering lessons learned from the COVID-19 pandemic. Policy Exchange: The Future of Global Health Security will take place Wednesday, October 13, 2021 at 5:30 p.m. ET in a virtual format. This event highlights faculty from
